Ichor is a specialty biopharmaceutical company focused on the innovation, development, and commercialization of high-purity plasma-derived therapeutics. Our integrated operations span the safe and compliant collection of human plasma, supported by stringent quality control, and a state-of-the-art fractionation facility that adheres to global GMP and regulatory standards. A multidisciplinary team of scientists and experts from all cross-functional functions drives our mission to deliver safe, reliable, life-saving therapies for patients with rare and serious conditions.